Promotion of tumor progression induced by continuous low-dose administration of antineoplastic agent gemcitabine or gemcitabine combined with cisplatin

Autor: Chen, Yanshen, Liu, Hua, Zheng, Qiaowei, Li, Houli, You, Huining, Feng, Yan, Feng, Weiyi
Zdroj: In Life Sciences 1 October 2022 306
Databáze: ScienceDirect